NFKB1 and osteoporosis: Osteoporosis and other systemic inflammatory bone diseases are characterized by dysregulated bone remodeling driven by chronic inflammation, increased cytokine release, and activation of the nuclear factor kappa B (NF-κB) signaling pathway.